Tokio Marine Asset Management’s bluebird bio BLUE Stock Holding History

Tokio Marine Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,343	Closed	-$525K	–	449
2021 Q1	$525K	Hold	1,343	–	–	0.05%	191
2020 Q4	$753K	Sell	1,343 -325	-19%	-$206K	0.08%	134
2020 Q3	$1.17M	Sell	1,668 -23	-1%	-$17.9K	0.15%	76
2020 Q2	$1.34M	Hold	1,691	–	–	0.19%	63
2020 Q1	$1.01M	Buy	1,691 +348	+26%	+$339K	0.17%	69
2019 Q4	$1.53M	Hold	1,343	–	–	0.23%	71
2019 Q3	$1.6M	Buy	1,343 +108	+9%	+$165K	0.27%	62
2019 Q2	$2.04M	Hold	1,235	–	–	0.36%	59
2019 Q1	$2.52M	Hold	1,235	–	–	0.47%	48
2018 Q4	$1.59M	Hold	1,235	–	–	0.32%	77
2018 Q3	$2.34M	Buy	1,235 +15	+1%	+$31K	0.41%	56
2018 Q2	$2.48M	Buy	1,220 +425	+53%	+$969K	0.45%	54
2018 Q1	$1.76M	Buy	+795	New	+$2.02M	0.31%	65

Other funds holding BLUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Tokio Marine Asset Management's BLUE Position: Q2 2021 in Review

Tokio Marine Asset Management sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 1,343 shares — an estimated $525K sold.

Tokio Marine Asset Management first reported a position in BLUE in Q1 2018 and held it in 13 quarters. The position peaked at $2.52M in Q1 2019. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

Tokio Marine Asset Management reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
Tokio Marine Asset Management sold 1,343 bluebird bio shares in Q2 2021, an estimated $525K.
Tokio Marine Asset Management first reported a position in bluebird bio in Q1 2018 and held it in 13 quarters.
Tokio Marine Asset Management's bluebird bio position peaked at $2.52M in Q1 2019.
232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Tokio Marine Asset Management's 13F filing for Q2 2021, filed 12 Aug 2021.